The influence of occupational exposure to arsenic and heavy metals on the activity of catepsins and their inhibitors in blood serum of copper smelters;Wpływ zawodowego narażenia na arsen i metale ciȩżkie na aktywność katepsyn i ich inhibitorów w surowicy krwi pracowników huty miedzi

Medycyna Pracy

Volumn 56, Issue 5, 2005, Pages 347-361

  Dynerowicz Bal, Ewa ^a,c   Andrzejak, Ryszard ^a,c   Antonowicz Juchniewicz, Jolanta ^a,c   Siewiński, Maciej ^b,c   Sujak, Elzbieta ^a,c   Smyk, Beata ^a,c  

^a Pneumonologii i Alergologii Akademii Medycznej w Warszawie   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c NONE   (Poland)

Author keywords

Arsenic; Cadmium; Cathepsins (CP); Inhibitors of cathepsins (CPI); Lead

Indexed keywords

ARSENIC; CADMIUM; CATHEPSIN; COPPER; HEAVY METAL; IRON; LEAD; MAGNESIUM; MANGANESE; SELENIUM; ZINC;

ADULT; AIR POLLUTANT; ARTICLE; BLOOD; CASE CONTROL STUDY; DRUG ANTAGONISM; ERYTHROCYTE; HUMAN; MALE; METABOLISM; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLAND; URINE;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; ARSENIC; CADMIUM; CASE-CONTROL STUDIES; CATHEPSINS; COPPER; ERYTHROCYTES; HUMANS; IRON; LEAD; MAGNESIUM; MALE; MANGANESE; METALLURGY; METALS, HEAVY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLAND; SELENIUM; ZINC;

EID: 27644440368     PISSN: 04655893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Desoize B.: Cancer and metals and metal compounds. Carcinogenesis. Crit. Rev. Oncol. Hematol., 2002;42:1-3
2. Steenland K., Boffetta P.: Lead and cancer in humans: where are we now? Am. J. Ind. Med., 2000;38:295-299
3. Lison, D., De boeck, M., Verougstraete, V., Kirsch-Wolders, M.: Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup. Environ. Med., 2001;58;619-625
4. Brömme D., Kaleta J.: Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr. Pharm. Design, 2002;8:1639-1658
5. Haczyńska H., Warwas M.: Katepsyna B. Udział w inwazji procesu nowotworowego i jego diagnostyce. Post. Hig. Med. Dośw., 1994;48:729-743
6. Lah T.T., Kokalj-Kunovar M., Turk V.: Cysteine proteinase inhibitors in human cancerous tissues and fluids. Biol. Chem. Hoppe-Seyler, 1990;371:199-203
7. Farinati R, Herszenyi L., Plebani M., Carraro P., De Paoli M., Cardin R. i wsp.: Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. Carcinogenesis, 1996;17:2581-2587
8. Henskens Y.M.C., Veerman E.C.I., Nieuw Amerongen A.V.: Cystatins in health and disease. Biol. Chem. Hoppe-Seyler, 1996;377:71-86
9. Křepela E., Procházka J., Kárová B., Čermák J., Roubková H.: Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma, 1998;45:318-331
10. Kos J., Nielsen H.J., Krašovec M., Christensen I.J., Cimerman N., Stephens R.W. i wsp.: Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin. Cancer Res., 1998;4:1511-1516
11. Kos J., Werle B., Lah T., Brunner N.: Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int. J. Biol. Markers, 2000;15:84-89
12. Antonowicz-Juchniewicz J.: Środowiskowy i zawodowy wpływ metali ciȩżkich na rozwój zmian patologicznych w naczyniach krwionośnych [praca na stopień naukowy doktora habilitowanego]. Akademia Medyczna, Wrocław 2001
13. Piomelli S.: A micromethod for free erythrocyte porphyrins: the FEP test. J. Lab. Clin. Med., 1973;81:932-940
14. Barrett A. J.: An improved color reagent for use in Barrett's assay of cathepsin B. Anal. Biochem., 1976;76:374-376
15. Minakata K., Assano M., Sato T., Harada N.: Assay of alpha-cysteine proteinase inhibitor in serum or plasma. Hoppe-Seyler's Z. Physiol. Chem., 1982;369:493-498
16. Miȩdzyresortowa Komisja ds. Najwyższych Dopuszczalnych Stȩżen i Natȩżeń Czynników Szkodliwych dla Zdrowia w Środowisku Pracy: Czynniki szkodliwe w środowisku pracy. Biuletyn Informacji Publicznej. Centralny Instytut Ochrony Pracy, Warszawa 2003, ss.122-123
17. Deutsche Forschungsgemeinschaft - Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area: List of MAK and BAT Values. Wiley-VCH, Weinheim 2003, s. 204
18. Siewiński M., Krȩcicki T., Jarmułowicz J., Berdowska L: Cysteine proteinase inhibitors in serum of patients with head and neck tumors. Diagn. Oncol, 1992;2:323-326
19. Jakubowski M., Trzcinka-Ochocka M., Hałatek T., Raźniewska G., Szymczak W: Integrated indexes of occupational exposure as predictors of kidney dysfunction. Int. J. Occup. Med. Environ. Heath, 2002;15:393-399
20. Biggs M.L., Kalman, D.A., Moore L.E., Hopenhayn-Rich C., Smith M.T., Smith, A.H.: Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res., 1997;386:185-195
21. Dynerowicz-Bal E., Antonowicz-Juchniewicz J., Skoczyńska A., Andrzejak R.: Influence of heavy metals (especially lead) on lipid metabolism and the oxidation-reduction status of the organism. W: Centeno J.A., Collery P., Vernet G., Finkelman R.B., Gibb H., Etienne J.C. [red.]. Metal Ions in Biology and Medicine. T. 6. J. Libbey Eurotext, Paris 2000, ss. 475-477
22. Wa̧sowicz W., Gromadzińska J., Rydzyński K.: Blood concentration of essential trace elements and heavy metals in workers exposed to lead and cadmium. Int. J. Occup. Med. Environ. Health, 2001;14:223-229
23. Lee B.K., Ahn K.D., Lee S.S., Lee G.S., Kim Y.B., Schwartz B.S.: A comparison of different lead biomarkers in their associations with lead-related symptoms. Int. Arch. Occup. Environ. Health, 2000;73:298-304
24. Ellingsen D. G., Thomassen Y., Aaseth J., Alexander J.: Cadmium and selenium in blood and urine related to smoking habits and previous exposure to mercury vapor. J. Appl. Toxicol., 1997;17:337-343
25. Concha G. Vogler G., Nermell B., Vahter M.: Intra-individual variation in the metabolism of inorganic arsenic. Int. Arch. Occup. Environ. Health, 2002;75:576-580
26. Heijne W.H., Stierum R.H., Slijper M., van Bladeren P.J., van Ommen B.: Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem. Pharmacol., 2003;65:857-875
27. Lockwood T.D.: Cathepsin B responsiveness to glutathione and lipoic acid redox. Antioxid. Redox Signal., 2002;4:681-691
28. Herwald H., Morgelin M., Svensson H. G., Sjobring U.: Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur. J. Biochem., 2001;268:396-404
29. Hengstler J.G., Bolm-Audorff U., Faldum A., Janssen K., Reifenrath M. Götte W. i wsp.: Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis, 2003;24:63-73
30. Schwerdtle T., Seidel A., Hartwig A.: Effect of soluble and particulate nickel compounds on the formation and repair of stable benzo[a]pyrene DNA adducts in human lung cells. Carcinogenesis, 2002;23:47-53